Author: Daniel Mollenkamp

FDA squeeze means more bad press for e-cigs

Written by Daniel Mollenkamp || 25th May 2018 || Regulatory briefing |

E-cigarettes have been hitting the headlines recently, thanks to recent actions by the US Food and Drug Administration (FDA), which has been battling against teen use, particularly Juul Labs’ Juul product. Juul has taken a large portion of...

Coming soon: deadline for product registration in the US

Written by Daniel Mollenkamp || 15th September 2017 || Regulatory briefing |

The deadline for the US Food and Drug Administration (FDA) product registrations for manufacturers is swiftly approaching. From 30th September, manufacturers need to register with the FDA and submit product lists, including labelling and advertisements, to the agency....